顺铂加卡培他滨诱导化疗治疗局部晚期鼻咽癌的疗效及毒副反应

顺铂加卡培他滨诱导化疗治疗局部晚期鼻咽癌的疗效及毒副反
应
杨利;徐志渊;李济时;陈志坚
【期刊名称】《现代肿瘤医学》
【年(卷),期】2018(026)004
【摘要】目的:诱导化疗联合同期放化疗可显著降低局部晚期鼻咽癌的局部进展和远处转移风险,但是目前尚无标准的诱导化疗方案.本文前瞻性研究顺铂加卡培他滨
诱导化疗在局部晚期鼻咽癌患者中的疗效及毒副反应.方法:2015年1月至2016
年12月期间初治局部晚期鼻咽癌患者56例,均接受PX方案(顺铂80mg/m2,第1天;卡培他滨1 000 mg/m2,每日2次口服;每3周为1个周期)诱导化疗3个周期.
后续放疗由放疗中心医生安排.3个周期PX化疗后采用世界卫生组织(WHO)疗效
评价标准评价疗效.根据“常见不良反应事件评价标准(CTCAE) 4.03版本”评估化疗毒副反应.结果:56例患者均顺利完成了3个周期的诱导PX化疗.PX方案化疗3
个周期后,鼻咽部和颈部的客观有效率(ORR)分别为78.6％[完全缓解率(CR)为
19.6％]和81.5％(CR率为7.4％),鼻咽部+颈部的总体ORR为85.7％(CR率为
3.6％).PX方案化疗期间3-4级白细胞/中性粒细胞减少、贫血、恶心/呕吐和电解
质紊乱发生率分别为14.3％、7.1％、5.4％和17.9％,没有发生3-4级手足综合征、腹泻及肾功能损害.没有发生治疗相关的死亡.结论:PX方案诱导化疗治疗局部晚期
鼻咽癌疗效好,耐受性好,值得进一步研究.%Objective:Induction chemotherapy(IC) plus concurrent chemoradiotherapy(CCRT) could significantly reduce the hazard of progression and distant metastasis in locally advanced nasopharyngeal carcinoma(LA-NPC).However,no standard
IC regimen is currently available.This study aims to prospectively evaluate the efficacy and toxicity of IC with cisplatin and capcitabine in the treatment of LA-NPC.Methods:From January 2015 to December 2016,fifty-six patients with LA-NPC were enrolled.All patients received 3 cycles of induction PX(cisplatin 80 mg/m2,day 1.Oral capecitabine 1 000
mg/m2,twice daily from day 1 ～ 14,repeated every 3 weeks).The following radiotherapy was determined by radiation oncologists.Tumor response was evaluated after 3 cycles of PX according to the World Health Organization(WHO) criteria.Toxicities were gauged based on the Common Terminology Criteria for Adverse Events version 4.03 (CTCAE
4.03).Results:All patients received 3 cycles of induction PX.The objective response rate(ORR) after 3 cycles of PX at the primary site and the neck region were 78.6％ [complete response (CR) was 19.6％] and 81.5％ (CR was 7.4％) respectively.The combined ORR of the primary site and the neck region was 8
5.7％ (CR was 3.6％).The incidence of grade 3-4
leukopenia/neutropenia,anemia,nausea/vomiting and electrolyte disturbance during PX were 14.3％,7.1％,5.4％ and 17.9％,respectively.No grade 3-4 hand-foot syndrome,diarrhea or renal impairment was observed.There were no treatment-related deaths.Conclusion:Induction PX is highly effective and well tolerated in LA-NPC and warrant further investigation.
【总页数】4页(P516-519)
【作者】杨利;徐志渊;李济时;陈志坚
【作者单位】香港大学深圳医院临床肿瘤中心,广东深圳518053;香港大学深圳医院临床肿瘤中心,广东深圳518053;香港大学深圳医院临床肿瘤中心,广东深圳518053;香港大学深圳医院临床肿瘤中心,广东深圳518053
【正文语种】中文
【中图分类】R739.6
【相关文献】
1.奈达铂或顺铂联合氟尿嘧啶诱导化疗加同步放化疗治疗局部晚期鼻咽癌近期疗效的对比研究 [J], 崔建东;徐子海;张羽;龙桂宁;李涛;梁春林;闻世龙
2.多西紫杉醇联合顺铂(TP)与顺铂联合5-FU(PF)方案诱导化疗治疗局部晚期鼻咽癌疗效比较 [J], 石明宏;程节凤;王琍;谢鸿寿;肖枚生;汤俊
3.奈达铂或顺铂加氟尿嘧啶同期放化疗治疗局部晚期鼻咽癌的疗效比较 [J], 唐爽;李素芳;林灿洁;文小芝
4.顺铂加卡培他滨与顺铂加氟尿嘧啶诱导化疗对局部晚期鼻咽癌的疗效比较 [J], 齐斌;林铃;黄中;徐稳深;尹文晶;刘锦全;陈冬平;余意;李铭仪;李洲宇;何璐
5.卡倍他滨与氟尿嘧啶分别联合奈达铂诱导化疗加同步放化疗治疗局部晚期鼻咽癌的疗效分析 [J], 李智颖;柳彬
因版权原因，仅展示原文概要，查看原文内容请购买。